NCT02617979

Brief Summary

The study of readmission is in its infancy in the surgical world, and there are no prospective studies, to the investigators' knowledge, evaluating the efficacy of interventions on preventing readmission following pancreatectomy. Undoubtedly, patients and their caregivers will play a key role in any useful intervention to reduce readmission. Therefore, the investigators' approach is to target perioperative education and engagement of patients and their caregivers in the postoperative recovery of pancreatectomy patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 1, 2015

Completed
8 months until next milestone

Study Start

First participant enrolled

July 20, 2016

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 8, 2020

Completed
Last Updated

May 15, 2020

Status Verified

May 1, 2020

Enrollment Period

2.7 years

First QC Date

November 18, 2015

Last Update Submit

May 12, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy of the SAFECARE at Home program as measured by readmission rate

    -The investigators hypothesize that the SAFECARE at HOME program intervention will reduce readmission by half (i.e. from 22% to 11%). The investigators will include a total of 225 evaluable patients in the study, randomized in a 2:1 ratio (i.e. 2 patients in the SAFECARE arm for every 1 patient in the standard of care arm). The designed sample size will allow 80% at a 1-sided alpha=0.1 to detect a 50% decrease in 30-day readmission.

    30 days

Secondary Outcomes (2)

  • Effect of the SAFECARE at Home program as measured by the number of follow-up visits

    Through 30 day post-discharge

  • Comparison of quality of life between SAFECARE at Home patients and patients who received standard post-operative care and education as measured by SF-36

    Up to 6 months post-discharge

Study Arms (2)

Arm 1: SAFECARE at Home

EXPERIMENTAL

* Patients randomized to the intervention arm will be assigned a username and password to access a SAFECARE at Home account via the internet. They will also be emailed a link to the site with their username and password. * The investigators have worked directly with SAFECARE at Home to create customized lessons for patients undergoing pancreatectomy. These lessons are comprehensive and encompass preoperative preparation as well as postoperative recovery and care. This includes videos, printed material, web-based material, and modules that focus on the pre-treatment, treatment, and follow-up care of patients undergoing surgery for pancreatic cancer. * All patients will receive standard pre- and post-operative instructions and care. This will include verbal education about the procedure by the surgeon as well as standard educational patient handouts, which are routinely provided preoperatively to pancreatectomy patients.

Other: SAFECARE at Home customized lessons

Arm 2: Standard of Care

NO INTERVENTION

-All patients will receive standard pre- and post-operative instructions and care. This will include verbal education about the procedure by the surgeon as well as standard educational patient handouts, which are routinely provided preoperatively to pancreatectomy patients.

Interventions

Arm 1: SAFECARE at Home

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled for major pancreatectomy (i.e., pancreaticoduodenectomy, total pancreatectomy, or a distal pancreatectomy).
  • At least 18 years of age.
  • Able to read and understand English (the SAFECARE at Home program is only implemented in English)
  • Has internet access.
  • Knowledge of the internet and how to use web-based programs.
  • Not pregnant or breastfeeding.
  • Able to understand and willing to sign an IRB-approved written informed consent document.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Links

Study Officials

  • Ryan C Fields, M.D.

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2015

First Posted

December 1, 2015

Study Start

July 20, 2016

Primary Completion

April 4, 2019

Study Completion

April 8, 2020

Last Updated

May 15, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations